THE DELTA-OPIOID RECEPTOR ANTAGONIST NALTRINDOLE PREVENTS SENSITIZATION TO THE CONDITIONED REWARDING EFFECTS OF COCAINE

被引:53
作者
SHIPPENBERG, TS
HEIDBREDER, C
机构
[1] Behavioral Pharmacol ogy and Genetics Section, NIDA Intramural Research Program, Baltimore, MD 21224
关键词
COCAINE; NALTRINDOLE; ENKEPHALIN; DELTA-OPIOID RECEPTOR; COCAINE-INDUCED SENSITIZATION;
D O I
10.1016/0014-2999(95)00185-N
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A conditioned place preference paradigm was used to determine whether: (i) prior exposure to cocaine results in an enhancement of its rewarding effects, and (ii) the delta-opioid receptor antagonist naltrindole can prevent the development of this response. Rats received daily injections of saline or cocaine (10.0 mg/kg i.p.) for 5 days in the colony room. Additional animals received naltrindole (0.03-0.3 mg/kg s.c.), lithium chloride (20 mg/kg s.c.) or vehicle prior to i.p. injections. Conditioning sessions (2 drug; 2 vehicle) commenced 3 days later. Cocaine (1.0-10.0 mg/kg) was ineffective as a conditioning stimulus in saline pre-exposed rats. In cocaine pre-exposed animals, however, doses of 5.0 and 10.0 mg/kg cocaine resulted in significant drug-induced place preferences. Significant cocaine-induced place preferences were also observed in animals which had received lithium chloride with the cocaine treatment regimen. In animals which had received naltrindole together with the chronic cocaine treatment regimen, cocaine failed to produce a conditioned response. These data demonstrate that the repeated administration of cocaine results in an enhancement of its rewarding effects (e.g. sensitization) and that this phenomenon is prevented by a delta-opioid receptor antagonist. Furthermore, the finding that naltrindole does not modify the acute rewarding effects of cocaine suggests a specific role of delta-opioid receptors in the sensitization process.
引用
收藏
页码:55 / 61
页数:7
相关论文
共 48 条
[1]   NALOXONE ATTENUATION OF THE EFFECT OF COCAINE ON REWARDING BRAIN-STIMULATION [J].
BAIN, GT ;
KORNETSKY, C .
LIFE SCIENCES, 1987, 40 (11) :1119-1125
[2]   MEDIAL FOREBRAIN-BUNDLE STIMULATION OR D-2 DOPAMINE RECEPTOR ACTIVATION INCREASES PREPROENKEPHALIN MESSENGER-RNA IN RAT STRIATUM [J].
BANNON, MJ ;
KELLAND, M ;
CHIODO, LA .
JOURNAL OF NEUROCHEMISTRY, 1989, 52 (03) :859-862
[3]   EFFECT OF INHIBITING ENKEPHALIN CATABOLISM IN THE VTA ON MOTOR-ACTIVITY AND EXTRACELLULAR DOPAMINE [J].
DAUGE, V ;
KALIVAS, PW ;
DUFFY, T ;
ROQUES, BP .
BRAIN RESEARCH, 1992, 599 (02) :209-214
[4]   THE PROENKEPHALIN A FRAGMENT, PEPTIDE E - CENTRAL PROCESSING AND CNS ACTIVITY INVIVO [J].
DAVIS, TP ;
PORRECA, F ;
BURKS, TF ;
DRAY, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 111 (02) :177-183
[5]  
DEVRIES TJ, 1995, IN PRESS PSYCHOPHARM
[6]   BLOCKADE OF COCAINE REINFORCEMENT IN RATS WITH DOPAMINE RECEPTOR BLOCKER PIMOZIDE, BUT NOT WITH NORADRENERGIC BLOCKERS PHENTOLAMINE OR PHENOXYBENZAMINE [J].
DEWIT, H ;
WISE, RA .
CANADIAN JOURNAL OF PSYCHOLOGY-REVUE CANADIENNE DE PSYCHOLOGIE, 1977, 31 (04) :195-203
[7]  
DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274
[8]  
EMMETTOGLESBY ME, 1992, BEHAV PHARMACOL, V3, P192
[9]   THE IMMUNO-CYTOCHEMICAL LOCALIZATION OF ENKEPHALIN IN THE CENTRAL NERVOUS-SYSTEM OF THE RAT [J].
FINLEY, JCW ;
MADERDRUT, JL ;
PETRUSZ, P .
JOURNAL OF COMPARATIVE NEUROLOGY, 1981, 198 (04) :541-565
[10]  
FONTANA D, 1993, BEHAV PHARMACOL, V4, P375